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Jeffrey A. Frelinger1
High-throughput assays have begun to revolutionize
modern biology and medicine. The advent of cheap
next-generation sequencing (NGS) has made it possi-
ble to interrogate cells and human populations as
never before. Although this has allowed us to investi-
gate the genetics, gene expression, and impacts of the
microbiome, there remain both practical and concep-
tual challenges. These include data handling, storage,
and statistical analysis, as well as an inherent problem
of the analysis of heterogeneous cell populations.
The Journal of Investigative Dermatology Symposium (2015) 17, 33–35;
doi:10.1038/jidsymp.2015.38
INTRODUCTION
During the last 10 years technical advances in molecular
biology and genetics have created the opportunity to produce
large amounts of data, heretofore impossible to produce.
Advances in DNA sequencing have shortened the time for the
collection of the raw sequencing data for a mouse or human
genome from years to days, and the costs have diminished
1,000-fold from millions to just few thousands of dollars. There
has been a similar decrease in the amount of material required
for generation of data from milligrams of purified DNA to being
able to interrogate a single cell for its genome, as well as its
RNA. The sensitivity of mass spectroscopy has also increased
spectacularly, which allows the total composition of a small
number of cells to be accessed, including not only proteins, but
lipids and carbohydrates as well.
The ability to generate vast amounts of genomic sequence
data has spurred the application of genome-wide association
studies (GWAS) to many human diseases including alopecia
areata. The first generation of studies explored the simplest
question: are there DNA sequences (and therefore perhaps
specific genes) that are associated with the disease. The next-
generation questions began as another simple question: Can
we detect differences in the RNA from affected and unaffected
individuals. From here arouse the first difficult problem, i.e.,
where to obtain RNA, as each cell has a distinctive RNA
expression pattern (transcriptome). The application to a
disease raises a complex theoretical problem, Where to look?
The target organ might not express any of the genes that are
critical to develop the disease, and concentration on that
organ might only reveal what we already know—that the
organ/cell type is being damaged. Finally, there is a practical
problem of access to tissues. Many diseases impact internal
organs that are not readily accessible to sampling, indeed in
humans the only readily accessible tissues are peripheral
blood and skin. Finally there is the proteome and the
phosphoproteome, as well as the lipidome that need to be
considered, I will briefly consider each of this in this short
review.
GENOME STUDIES
Gene disease association studies have a long history; it has
been known for hundreds of years that diseases can run in
families. More than 1,400 diseases have been ascribed to a
single gene out of the 47,000 described. Although this
approach has been fruitful in understanding the principles of
disease susceptibility, it does not allow us to really understand
the basis of complex genetic diseases that are the result of the
interaction of multiple genes and environmental influences.
Alopecia areata is not caused by a single mutation and even
identical twins are not always affected (Rodriguez et al.,
2010), demonstrating that both genetics and the
environment contribute. Nevertheless genes are important.
Like all complex traits, alopecia areata was not amenable to
simple genetic analysis because of if its multigenic nature and
variable penetrance. When it became possible to identify
orders of magnitude, more human polymorphisms using
single-nucleotide polymorphisms (SNPs), and the coverage
of the genome allowed definition of common allelic variants,
it was then possible to begin to map genes that contributed to
a phenotype, without being the sole cause. These genes,
referred to as quantitative trait loci (QTL) have been known for
nearly 100 years, although understanding of their function
have been difficult. A technical development, the use of
arrays, where SNPs could be displayed allowed the
simultaneous genotyping of tens of thousands of alleles from
a single sample easily and cheaply. This analysis using SNP
polymorphisms and a disease phenotype became known as
GWAS. Although GWAS have been used for complex traits
since 2006 (http://www.genome.gov/gwastudies/), the first
study to show significant associations with study on alopecia
areata was only published in 2010 (Petukhova et al., 2010).
This data set resulted in B600 million data points. This
demonstrates the second challenge of big data—how to
handle and analyze the data. Many challenges remain for
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the analysis of GWAS studies; these include how to remove
‘‘outlier’’ data, how to more finely map regions and how to go
to the next steps of assigning gene function and relating that to
the disease. Even the best of circumstances can result in
difficulties. In the 2010 paper, 139 SNPs were associated with
alopecia areata with P-values o107.The subsequent analy-
sis, appropriately examined the SNPs for block of each
chromosome that were associated by linkage disequilibrium
(a block of a chromosome where genes are inherited together
more often than by chance), and this resulted in smaller
number of candidates. It must be emphasized that GWAS and
similar studies cannot show causation, but only association.
When the authors examined the segments described, they
found several that were previously associated with other
autoimmune diseases, most notably the HLA region. HLA is
the most often single region that impacts autoimmunity
(Trowsdale and Knight, 2013). Immunologically, such
associations make sense, and HLA is associated with Type 1
diabetes, multiple sclerosis and many other diseases.
There are important statistical challenges associated with
the interpretation of GWAS studies. Although the most
obvious is the very large numbers of comparisons that are
made—often referred as small n large P, meaning there is a
bivariate outcome—disease or no disease, but hundreds of
thousands of SNPs tested. A recent paper reviews the current
methodology used and their strengths and weaknesses
(Rodriguez et al., 2010). This describes many of the
problems, focusing on effect size and the ways to increase
power, along with the need to perform meta-analyzes. Thus,
although there still remain challenges based on the biological
reality that variation among many genes can have important,
but small additive effects on the development of a disease,
there remains the biological challenge of understanding the
mechanisms of disease induction.
NGS can also be applied to understanding of immune
repertoires (Calis and Rosenberg, 2014). For this review we
will briefly discuss the immune repertoire. As there is ample
evidence, from direct studies and clinical experience, as well as
from the genomics that the T-cell immune response is a major
player in the pathogenesis of alopecia areata, a reasonable
expectation is that the T-cell receptor repertoire would give
both clues and targets for treatments. NGS has allowed
scientists to expand the numbers of T-cell receptor sequences
from 100 s to millions. Many studies are ongoing attempting to
define disease-specific signatures from the sequenced of
unselected peripheral blood T cell. All of these studies require
the small number of potentially informative sequences to be
found among the vast majority of other sequences. This is
because in the periphery at most a few tenths of a percent of the
T cells are specific for a given antigen, whereas the remainder
are essentially noise. As the response to a given antigen is likely
heterogeneous, from a 10-ml sample there will only be a few
hundred antigen-specific T cells in the midst of millions. This
requires sophisticated statistical analysis and replication,
because the specific sequences for a given antigen are not
likely to be shared among individuals. Nonetheless, this remains
an important approach, and has the potential for both diagnosis
and treatment.
The microbiome, though known for many years, had
remained a black box. The majority of the millions of bacteria
that inhabit the gastrointestinal (GI) tract are anaerobes, and
are effectively unculturable, thus making their analysis impos-
sible. The advent of NGS and generation of promiscuous 16 S
ribosomal DNA primers has allowed the bacterial contents of
the human gut to become accessible. http://commonfund.-
nih.gov/hmp/databases, although a comparable database for
the mouse microbiome is not available (Lita Proctor, NHGRI,
personal communication). Because the microbiome can be
sampled over time from the feces, and as the identification of
bacterial species uses PCR, unculturable bacteria are easily
detected, thus the viability of the bacteria is not important.
Although most 16s sequencing is unable to define the species
of the bacteria, it is adequate to define the family or genus,
and thus allow monitoring of changes over time. Of equal
importance has been the realization that the immune system
development is dependent on the microbiota. Germ-free mice
have immature immune systems that will only develop
when they are colonized by bacteria (Bauer et al., 1963).
Even in specific pathogen-free mice, one bacteria, segmented
filamentous bacteria (SFB), an unculturable anaerobe, is
required for the efficient development of Th17 cells (Ivanov
et al., 2009). Although C57BL/6J mice not colonized by SFB
are able to produce Th17, e.g., in Francisella infection of the
lung, and in other systems as well (Langrish et al., 2005;
Woolard et al., 2008; Wang et al., 2014), they have many
fewer resident cells, so a single bacteria in the microbiome
can influence the immune response. Interestingly when those
mice are colonized with SFB, they begin to produce more
Th17 cells. The overall composition of the microbiome can
influence not only the immune response in the GI tract, but
also the soma (McDermott and Huffnagle, 2014). Recently
there was a report that the Th17 are largely SFB specific (Yang
et al., 2014), although this does not account from strong Th17
responses in other systems by SFB-negative mice. This seems
to be particularly important in regulating the growth of
pathogens, although the mechanisms are unclear. This has
brought about a spate of treatments introduced into the clinic
in the absence of well-controlled efficacy studies of fecal
transplants. The efficacy has only been reasonably established
in Clostridium difficile infection (de Vrieze, 2013).
In contrast to the GI tract, the description of the microbiota
of the skin has not been well studied. The first attempts with
relatively small numbers of subjects revealed that different
areas of the skin have distinct microbiota, as might have been
expected from the quite different environments (Oh et al.,
2014). As dysregulation of the microbiota in the gut
contributes to IBD, as well as other GI diseases, it seems
reasonable that the microbiota of the skin could also
contribute to skin disease. Indeed psoriatic skin differed in
composition of the microbiome from healthy skin on the same
patient (Alekseyenko et al., 2013). Like all of these studies,
there have not yet been studies that demonstrated causation,
but only association. In other setting, such as obesity, there
have been fecal transplants that have been able to change
animal phenotype from fat-to-lean, by altering the microbiome
(Ellekilde et al., 2014).
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The final nucleic acid-based approach that generates large
data sets is RNAseq, where the total RNA (excluding rRNA)
from a cell or tissue is sequenced. This allows the quantitation
of the number of copies of RNA transcript present and how the
number changes over time. It can also reveal the changes in
splicing patterns. This data, combined with the GWAS data
can be evaluated using pathway software, such as KEGG
(http://www.genome.jp/kegg/) and Ingenuity (http://www.in-
genuity.com/products/ipa), which help organize changes seen
into signaling and metabolic pathways. These provide starting
points for mechanistic experiments to identify critical pathways
in responses, which provide potential therapeutic targets. A
small study using microarray (an earlier technique for assessing
the transcriptome) using peripheral blood mononuclear cells
(PBMCs) and has allowed the definition disease signature of
heritability, disease, and severity (Coda et al., 2010).
There are several other producers of big data, most use mass
spectroscopy. They include proteomic, lipidomic, and glyco-
mic analysis that examine the mixture of proteins, lipid or
carbohydrates in different tissues under different conditions.
These changes are analogous to RNAseq, but they measure the
end point of the process and can also monitor important post-
translation events. These include, but are not limited to protein
processing (cleavage, glycosylation and lipidation, production
of polysaccharides, and lipids as well). These data sets are not
as well curated as the nucleic acid data sets, but can have
significant impact.
All of the big data methodologies are constantly evolving
and improving. At the same time vast amounts of data have
been deposited:
 Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/
geo/).
 (http://keck.med.yale.edu/proteomics/yped/index.aspx),
proteomics.
 (http://www.lipidmaps.org/resources/resources.html),
lipidomics.
 (http://www.functionalglycomics.org/), glycomics.
These and other databases are increasingly important, and
allow for mining of data that is already generated. This does
not minimize the need to collect new data sets in a thoughtful
manner. A recent publication (Hoek et al., 2015) examined
differences among hematopoietic cells types following
influenza vaccination. The important observation is that
each of the separated populations differs from the unsorted
population and changes that are seen in the individual
population are not reflected in the overall PBMC population.
It is possible that a larger data set than the four individuals
followed in this study might have provided enough power to
statistically detect the differences that were apparent in the
purified population.
In conclusion, big data has enormous promise for the
understanding of alopecia areata, as well as many other
human diseases. At the current time the ability to generate
data has outstripped the ability to effectively utilize it. The
informatics needs to keep pace with the molecular biology.
CONFLICT OF INTEREST
JAF owns Amgen stock, has received grant support from the NIH, has received
royalties from the sale of monoclonal antibodies through the University of
Southern California.
ACKNOWLEDGMENTS
Funding for the Summit and the publication of this supplement was provided
by the National Alopecia Areata Foundation and was made possible (in part)
by a grant (R13AR067088-01) from the National Institute of Arthritis and
Musculoskeletal and Skin Diseases and all co-funding support was provided by
the National Center for Advancing Translational Sciences.
DISCLAIMER
The views expressed in written conference materials or publications and by
speakers and moderators do not necessarily reflect the official policies of the
Department of Health and Human Services; nor does mention of trade names,
commercial practices, or organizations imply endorsement by the U.S.
Government.
REFERENCES
Alekseyenko AV, Perez-Perez GI, De Souza A et al. (2013) Community
differentiation of the cutaneous microbiota in psoriasis. Microbiome 1:31
Bauer H, Horowitz RE, Levenson SM et al. (1963) The response of the
lymphatic tissue to the microbial flora. Studies on germfree mice. Am J
Pathol 42:471–83
Calis JJ, Rosenberg BR (2014) Characterizing immune repertoires by high
throughput sequencing: strategies and applications. Trends Immunol
35:581–90
Coda AB, Qafalijaj Hysa V, Seiffert-Sinha K et al. (2010) Peripheral blood gene
expression in alopecia areata reveals molecular pathways distinguishing
heritability, disease and severity. Genes Immun 11:531–41
de Vrieze J (2013) Medical research. The promise of poop. Science 341:
954–957
Ellekilde M, Selfjord E, Larsen CS et al. (2014) Transfer of gut microbiota from
lean and obese mice to antibiotic-treated mice. Sci Rep 4:5922
Hoek KL, Samir P, Howard LM et al. (2015) A cell-based systems biology
assessment of human blood to monitor immune responses after influenza
vaccination. PLoS One 10:e0118528
Ivanov II, Atarashi K, Manel N et al. (2009) Induction of intestinal Th17 cells by
segmented filamentous bacteria. Cell 139:485–98
Langrish CL, Chen Y, Blumenschein WM et al. (2005) IL-23 drives a
pathogenic T cell population that induces autoimmune inflammation.
J Exp Med 201:233–40
McDermott AJ, Huffnagle GB (2014) The microbiome and regulation of
mucosal immunity. Immunology 142:24–31
Oh J, Byrd AL, Deming C et al. (2014) Biogeography and individuality shape
function in the human skin metagenome. Nature 514:59–64
Petukhova L, Duvic M, Hordinsky M et al. (2010) Genome-wide association
study in alopecia areata implicates both innate and adaptive immunity.
Nature 466:113–7
Rodriguez TA, Fernandes KE, Dresser KL et al. (2010) Concordance rate of
alopecia areata in identical twins supports both genetic and environ-
mental factors. J Am Acad Dermatol 62:525–7
Trowsdale J, Knight JC (2013) Major histocompatibility complex genomics and
human disease. Annu Rev Genomics Hum Genet 14:301–23
Wang W, Zhou A, Zhang X et al. (2014) Interleukin 17 A promotes
pneumococcal clearance by recruiting neutrophils and inducing apoptosis
through a p38 mitogen-activated protein kinase-dependent mechanism in
acute otitis media. Infect Immun 82:2368–77
Woolard MD, Hensley LL, Kawula TH et al. (2008) Respiratory Francisella
tularensis live vaccine strain infection induces Th17 cells and prostaglan-
din E2, which inhibits generation of gamma interferon-positive T cells.
Infect Immun 76:2651–9
Yang Y, Torchinsky MB, Gobert M et al. (2014) Focused specificity of intestinal
TH17 cells towards commensal bacterial antigens. Nature 510:152–6
JA Frelinger
Big Data
www.jidonline.org 35
